A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions

Obesity

Interventions

DRUG

NNC0487-0111

Participants will get one tablet to swallow at the same time of the day.

DRUG

Placebo (NNC0487-0111)

Participants will get one tablet to swallow at the same time of the day.

Trial Locations (1)

Hakata Clinic, Fukuoka